NYMOX PHARMACEUTICAL CORP

Nymox Pharmaceutical Corp.

Biotechnology • Healthcare • Nassau, Bahamas • NYMXF (OQB)

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert, a test for determining smoking status; and TobacAlert, a test for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment and prevention of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas.

Stock Performance (90 Days)

Data through Dec 24, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Nymox drama heightens as biotech sues AscellaHealth for $250M in damages - Fierce Biotech
Fierce Biotech • Nov 10
Is Nymox Pharmaceutical (NASDAQ:NYMX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Yahoo Finance • Mar 21
'Transparent mischief' and 'malfeasances' no more: Nymox's legal battle in the Bahamas comes to a close - Fierce Biotech
Fierce Biotech • Mar 27
Top 10 Wall Street Losers of 2014 - Genetic Engineering and Biotechnology News
Genetic Engineering and Biotechnology News • Jan 19
Another refuse-to-file for a small biotech — is the FDA using RTFs to manage its workload? - Endpoints News
Endpoints News • Jun 2

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has NYMOX PHARMACEUTICAL CORP had layoffs?
No layoff events have been recorded for NYMOX PHARMACEUTICAL CORP in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is NYMOX PHARMACEUTICAL CORP in?
NYMOX PHARMACEUTICAL CORP operates in the Biotechnology industry, within the Healthcare sector.
Is NYMOX PHARMACEUTICAL CORP a publicly traded company?
Yes, NYMOX PHARMACEUTICAL CORP is publicly traded under the ticker symbol NYMXF on the OQB. The company has a market capitalization of approximately $0.01 billion.
Where is NYMOX PHARMACEUTICAL CORP headquartered?
NYMOX PHARMACEUTICAL CORP is headquartered in Nassau, Bahamas.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.